scientific program • symposia - American Society for Reproductive ...

Disclosure Statements/Conflict of Interest Policy
Honoraria
The following speakers may receive
honoraria and/or discounted or free
registration:
• Plenary Speakers
• Postgraduate Course Faculty
• Symposia Speakers
• Interactive Session Speakers
The following speakers do not
receive honoraria:
• Roundtable Presenters
• Abstract Presenters
• Video Presenters
Disclosure Statements
Postgraduate Faculty, Symposia
Speakers, Plenary Lecturers, Abstract
Authors, Abstract Graders, Roundtable
Presenters, Video Presenters,
and Interactive Speakers are
required to disclose commercial
relationships or other activities that
might be perceived as potential
conflicts of interest.
Postgraduate course faculty
disclosures wiill be listed in the course
syllabi.
Symposium speakers’ disclosures will
be presented in handout materials,
as well as on slides.
Disclosures from speakers in the
Plenary Sessions, Interactive Sessions,
Roundtables, Videos and Symposia
will be published in the Final Program.
Abstract authors’ disclosures will be
published in the 2010 Program
Supplement.
Each presenter should reveal his/her
disclosure information during his/her
presentation, preferably with the
visual aid of a slide.
Roundtable presenters should
provide a copy of their disclosure
forms to the participants at their
table.
AMERICAN SOCIETY FOR REPRODUCTIVE MEDICINE
2010 Conflict of Interest Policy
for Invited Speakers
As a provider of continuing medical education (CME) accredited
by the Accreditation Council for Continuing Medical Education
(ACCME), the American Society for Reproductive Medicine must
ensure balance, independence, objectivity and scientific rigor in all
its educational activities. All presenters must disclose to the learners
any commercial or financial interests and/or other relationships
with manufacturers of pharmaceuticals, laboratory supplies and/or
medical devices. All relationships, whether or not they directly apply
to this CME event, must be disclosed. All non-FDA approved uses of
products must be clearly identified. Disclosures may be made in the
form of a slide, printed material, or oral statement.
The intent of this disclosure is not to prevent a speaker with a
commercial or financial interest from making a presentation. The intent
is to assist ASRM in resolving conflicts of interest and to provide learners
with information on which they can make their own judgments
regarding any bias. Although ASRM reviews and resolves potential
conflicts of interest, it remains for the audience to determine whether
the speaker’s interests or relationships may influence the presentation
with regard to exposition or conclusion.
Disclosures will be revealed to the learners. For postgraduate
courses, disclosure information will be provided in the syllabus. For
other activities, where no syllabus or other similar printed material is
available, disclosures must be made verbally to the audience by the
speakers, preferably with the visual aid of a slide.
For those situations where there is no potential for conflict of interest,
the portion of the form that so states should be completed. In those
situations where a speaker does not complete a form or refuses to
complete a form, the individual is ineligible to participate as a speaker
in the CME activity.
Speakers should also reveal to the audience any “off label” uses
(not approved by the FDA) of any drugs or products discussed.
Abstract authors’ disclosures are listed in the
2010 Program Supplement. Speakers in the
Symposia and Interactive, Video, Roundtable
and Abstract Sessions have also complied with
ASRM policies and their disclosures are on file in
the ASRM office. The speaker should reveal this
information during his/her presentation, preferably
with the visual aid of a slide.
11